Karyopharm Therapeutics Presents Positive Clinical Data on the Activity of Selinexor in Combination with Other Anticancer Agents ...
- Selinexor Demonstrates Promising Activity and Tolerability in Combination with Other Active Agents - - Encouraging Efficacy and Tolerability Observed in Patients with Heavily Pretreated Refractory Myeloma and Relapsed/Refractory Acute Myeloid Leukemia - …